If eligible commercially insured patients need assistance with their out-of-pocket costs, KADCYLA Access Solutions can refer them to the Genentech Oncology Co-pay Assistance Program. To get started, call (855) MYCOPAY (855-692-6729) or visit CopayAssistanceNow.com. Enroll Your Patient
Full Answer
What is Kadcyla used to treat?
Kadcyla (ado-trastuzumab emtansine) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer and Breast Cancer - Metastatic.
How much does Kadcyla cost?
The cost for Kadcyla intravenous powder for injection 100 mg is around $3,451 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
What is a patient assistance program?
Patient Assistance Programs for Kadcyla Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program. Provider: Patient Access Network Foundation (PAN)
What is kadcyla patient assistance?
What is kadcyla used for?
What is Genentech Access to Care Foundation?
How much does a free drug card save?
Is Kadcyla valid with insurance?
Does Kadcyla offer rebates?
See 3 more
About this website
Does Kadcyla cause weight gain?
Kadcyla side effects Symptoms to watch for include swelling of the ankles or legs, shortness of breath, cough, or weight gain of more than 5 pounds in less than 24 hours. Lung problems: Kadcyla may cause inflammation of the lungs, which can be life-threatening.
How long is Kadcyla treatment?
KADCYLA is given for 14 cycles in early breast cancer For HER2+ early breast cancer, KADCYLA is given every 3 weeks for 14 rounds of infusion—sometimes called "cycles"—unless the cancer comes back or side effects cause the treatment to be stopped sooner. Treatment with KADCYLA typically would last less than a year.
When did Kadcyla get metastatic breast cancer?
On May 3, 2019, the U.S. Food and Drug Administration (FDA) approved the targeted therapy Kadcyla (chemical name: T-DM1 or ado-trastuzumab emtansine) to treat early-stage HER2-positive breast cancer after surgery if there were cancer cells found during surgery (residual disease) after treatment with a taxane ...
When should I stop Kadcyla?
If you have HER2+ metastatic breast cancer that has spread to other parts of the body, Kadcyla is given once every 3 weeks on an ongoing basis. In both cases, you may need to stop the medicine if the cancer returns or the side effects become too serious for you to continue treatment.
What is the success rate of Kadcyla?
The study was designed to measure disease-free survival, which is how long the patient stayed alive and cancer-free. After 3 years, the rate of disease-free survival was 88% in the Kadcyla group compared with 77% in the Herceptin group.
Can you drive on Kadcyla?
Effects on the nervous system This treatment can affect the nervous system. You may feel confused, dizzy or unsteady. Tell your doctor or nurse straight away if you notice this. If you have any of these symptoms, it is important not to drive or operate machinery.
Do you lose your hair on Kadcyla?
Does Kadcyla cause hair loss? Kadcyla doesn't cause hair loss in most people who take the drug. And hair loss wasn't reported as a side effect in Kadcyla's prescribing information. In a trial that compared Kadcyla with another cancer treatment, hair loss did occur.
Is Kadcyla considered chemotherapy?
Kadcyla (ado-trastuzumab emtansine) is a new class of chemotherapy drug called an antibody-drug conjugate used to treat breast cancer.
When was Kadcyla developed?
In 2013, trastuzumab emtansine was approved in the United States for the treatment of adults with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination.
Does neuropathy go away after Kadcyla?
Some people having trastuzumab emtansine experience numbness or tingling in their hands and feet. This is due to the effect of trastuzumab emtansine on the nerves and is known as peripheral neuropathy. In most cases it is mild and usually goes away soon after treatment stops.
How bad are Kadcyla side effects?
Taking Kadcyla may lead to severe heart problems, such as decreased heart function, and congestive heart failure (CHF). With CHF, your heart can't pump blood efficiently. Kadcyla has a boxed warning about the risk of this side effect. This is a serious warning from the Food and Drug Administration (FDA).
Can you drink alcohol while on Kadcyla?
You may feel tired or dizzy after your treatment. What NOT to DO while on this medication: DO NOT smoke or drink alcohol while on treatment without talking to your health care team first. Smoking and drinking can make side effects worse and make your treatment not work as well.
How long is Kadcyla infusion?
This image shows that the first infusion of KADCYLA takes 90 minutes. If prior infusions were well tolerated, all other infusions take 30 minutes. Your healthcare team will wait at least 90 minutes after the first infusion, and at least 30 minutes after each following infusion, to check for any reactions.
Is Kadcyla considered chemotherapy?
Kadcyla (ado-trastuzumab emtansine) is a new class of chemotherapy drug called an antibody-drug conjugate used to treat breast cancer.
Is Kadcyla better than Herceptin?
Results from the KATHERINE trial suggest that Kadcyla (chemical name: T-DM1 or ado-trastuzumab emtansine) improves disease-free survival compared to Herceptin (chemical name: trastuzumab) in people diagnosed with early-stage, HER2-positive breast cancer who have cancer cells found in tissue removed during surgery after ...
Do you lose your hair with Kadcyla?
Kadcyla doesn't cause hair loss in most people who take the drug. And hair loss wasn't reported as a side effect in Kadcyla's prescribing information. In a trial that compared Kadcyla with another cancer treatment, hair loss did occur. But it wasn't a common side effect with either drug.
Kadcyla too costly for use on the NHS | News | News | NICE
Kadcyla is a treatment for HER2-positive breast cancer which has spread to other parts of the body that cannot be surgically removed and has stopped responding to initial treatment. The drug costs around £90,000 per patient at its full list price. Earlier this year, Roche the manufacturer of the ...
KADCYLA - Find The Best Price Near You | WellRx
How much does KADCYLA cost near you? Find the best KADCYLA prices near you now with our cost comparison tool and start saving today.
KADCYLA® (ado-trastuzumab emtansine) in HER2+ Breast Cancer
Who is KADCYLA for? Early Breast Cancer. KADCYLA is a prescription medicine used as an adjuvant (after surgery) treatment for HER2-positive early breast cancer when the patient has taken neoadjuvant (before surgery) treatment including a taxane and trastuzumab (Herceptin ®) and there is cancer remaining in the tissue removed during surgery.. Patients are selected for therapy based on an FDA ...
Breastcancer.org - Breast Cancer Information and Support
Redirecting to https://www.breastcancer.org/treatment/targeted_therapies/kadcyla (308)
What is kadcyla patient assistance?
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
What is kadcyla used for?
Kadcyla (ado-trastuzumab emtansine) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer, and Breast Cancer - Metastatic.
What is Genentech Access to Care Foundation?
The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Is Kadcyla valid with insurance?
Prices are for cash paying customers only and are not valid with insurance plans. This Kadcyla price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Does Kadcyla offer rebates?
Kadcyla Genentech Oncology Co-pay Assistance Program Rebate:Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if they paid the provider directly for treatment; for additional information contact the program at 855-692-6729.
An Alternative to Kadcyla Patient Assistance Programs
If you or your loved one is in this difficult situation, Welcome Funds may have a solution. We help cancer patients and their families relieve financial stress by converting their life insurance benefits into a lump sum cash payment that can be used as a personal health care fund.
About Welcome Funds
Founded in 2000, Welcome Funds has helped thousands of Americans qualify for a life insurance settlement. We are licensed throughout the nation to offer this financial option to policyholders and have provided more than $850Million in settlement proceeds to our clients.
Referrals to Independent Co-pay Assistance Foundations
If you need help with the co-pay for your Genentech medicine, KADCYLA Access Solutions can refer you to an independent co-pay assistance foundation.
Referrals to the Genentech Patient Foundation
The Genentech Patient Foundation provides free Genentech medicine to people who meet income guidelines and:
Referrals to the Genentech Oncology Co-pay Assistance Program
KADCYLA Access Solutions can refer you to the Genentech Oncology Co-pay Assistance Program. It can help you with the out-of-pocket costs for your Genentech medicine, if you’re eligible.
What is kadcyla patient assistance?
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
What is kadcyla used for?
Kadcyla (ado-trastuzumab emtansine) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer, and Breast Cancer - Metastatic.
What is Genentech Access to Care Foundation?
The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Is Kadcyla valid with insurance?
Prices are for cash paying customers only and are not valid with insurance plans. This Kadcyla price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Does Kadcyla offer rebates?
Kadcyla Genentech Oncology Co-pay Assistance Program Rebate:Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if they paid the provider directly for treatment; for additional information contact the program at 855-692-6729.
